{
    "clinical_study": {
        "@rank": "99306", 
        "arm_group": [
            {
                "arm_group_label": "Negative Pressure Wound Therapy (NPWT)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "standard prophylactic  therapy", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is a prospective, single center, unblinded, randomized, controlled study to\n      assess the safety and efficacy of negative pressure wound therapy in preventing infections\n      after TKA surgery . The study will enroll 316 patients that will undergo TKA. patients will\n      be randomized to the treatment group and undergo the study intervention - (NPWT) The\n      intervention will take place at the end of the surgery. The  Patients that are randomized to\n      the control group will receive standard treatment. Both groups will be assessed at  two\n      weeks and six weeks. period."
        }, 
        "brief_title": "Negative Pressure Wound Therapy -PREVENA in Prevention of Infections After Total Knee Arthroplasty (TKA)", 
        "completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Total Knee Replacement", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ages: 18 to 80\n\n          -  Males- not involved in active military duty.\n\n          -  Females-non child bearing potential, or females of child-bearing potential who have a\n             negative pregnancy test (hCG urine) within 72 hours of informed consent.\n\n        Exclusion Criteria:\n\n          -  Active systemic or local infection.\n\n          -  History of malignancy, radiotherapy, or chemotherapy for malignancy (except BCC of\n             the skin)\n\n          -  Active autoimmune disease.\n\n          -  Any past or present immunosuppressive treatment.\n\n          -  Current treatment with chemotherapeutic agents\n\n          -  History of metabolic bone disease (primary or secondary).\n\n          -  Chronic renal insufficiency (defined by 50% increase of normal levels)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "April 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02118558", 
            "org_study_id": "0020-14-HMO-CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Negative Pressure Wound Therapy (NPWT)", 
                "intervention_name": "Negative Pressure Wound Therapy (NPWT)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "standard prophylactic  therapy", 
                "description": "administration of antibiotics before the first incision, keeping the surgery field sterile and performing several rinsing", 
                "intervention_name": "standard prophylactic  therapy", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 17, 2014", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint of the study is to evaluate the proportion of infections at the  treatment and control groups after six weeks", 
            "measure": "The primary endpoint of the study is to evaluate the proportion of infections at the  treatment and control groups after six weeks", 
            "safety_issue": "No", 
            "time_frame": "six weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02118558"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To assess the proportion on infections at two  weeks and 6 weeks of follow-up.", 
                "measure": "1. To assess the proportion on infections at two  weeks and 6 weeks of follow-up.", 
                "safety_issue": "No", 
                "time_frame": "two weeks and six weeks"
            }, 
            {
                "description": "The number of patients recommended to undergo further procedural intervention because of the infection.", 
                "measure": "The number of patients recommended to undergo further procedural intervention because of the infection.", 
                "time_frame": "12 MONTHS"
            }
        ], 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}